A
Atlantic Central Enterprises Ltd. Stock Analysis ALCN
Atlantic Central Enterprises Ltd. owns patents of trans dermal drug delivery and skin permeation technology. The firm engages in electromedical and electrotherapeutic apparatus manufacturing.
Read More Atlantic Central Enterprises Ltd (ALCN) Chart
Key Statistics of Atlantic Central Enterprises Ltd (ALCN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
68.78KP/E Ratio (TTM)
-52 Week Range
Market Cap
-Avg. Volume
68.78KDividend Yield
-Financial Metrics & Statements of Atlantic Central Enterprises Ltd (ALCN)
FAQ's for Atlantic Central Enterprises Ltd (ALCN)
- According to Musaffa’s Shariah screening methodology, Atlantic Central Enterprises Ltd (ALCN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.